Bio-Rad Laboratories (NYSE:BIO) Price Target Lowered to $392.00 at Royal Bank of Canada
Bio-Rad Laboratories (NYSE:BIO – Free Report) had its target price decreased by Royal Bank of Canada from $409.00 to $392.00 in a research note published on Friday morning,Benzinga reports. Royal Bank of Canada currently has an outperform rating on the medical research company’s stock. A number of other research analysts also recently weighed in on […]
Bio-Rad Laboratories (NYSE:BIO – Free Report) had its target price decreased by Royal Bank of Canada from $409.00 to $392.00 in a research note published on Friday morning,Benzinga reports. Royal Bank of Canada currently has an outperform rating on the medical research company’s stock. A number of other research analysts also recently weighed in on […]
-ltd-logo-1200x675.png?v=20241211120412&w=240&h=240&zc=2){kind=logo}
